References
- Gaynon PS, Lustig RH. The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular and clinical considerations. J Pediatr Hematol Oncol. 1995;17(1):1–12.
- Schimmer BP, Parker KL. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: Inhibitors of the synthesis and action of adrenocortical hormones. In: Hardman JG, Limbird LE, (eds.) Goodman and Gillman's. The pharmacological basis of therapeutics. 9th ed. New York: Mc Graw Hill 1996. p. 1459–85.
- Schlaghecke R, Kornely E, Santen R. The effect of long term glucocrticoid therapy on pituitary adrenal responses to exogenous corticotrophin-releasing hormone. N Engl J Med. 1992;326:226–30.
- Bangar V, Clayton RN. How reliable is the short synacthen test for the investigation of the hypothalamic pituitary adrenal axis. Eur J Endocrinol. 1998;139(6):580–3.
- Oelkers W. The role of high and low dose corticotropin tests in the diagnosis of secondary adrenal insufficiency. Eur J Endocrinol. 1998;139:567–70.
- Thaler LM, Belvins LS Jr. The low dose (1 ug) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab. 1998;83(8):2726–9.
- Parker LN. Control of adrenal androgen secretion. Endocrinol Metab Clin North Am. 1991;20(2):401–21.
- Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med. 1997;337:1285–92.
- Naito Y, Fukata J, Tamai S, Seo N, Nakai Y, Mori K, et al. Biphasic changes in hypothalamo-pituitary adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab. 1991;73:111–7.
- Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW. Natural history of pituitary adrenal recovery following long term suppression with corticosteroids. J Clin Endocrinol mETAB. 1965;25:11–6.
- Felner EI, Thompson MT, Ratliff AF, White PC, Dickson BA. Time course of recovery of adrenal function in children treated for leukemia. J Pediatr. 2000;137:21–4.
- Rix M, Birkebaek NH, Rosthoj S, Clausen N. Clinical impact of corticosteroid induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low dose adrenocorticotropin test. J Pediatr. 2005;147:645–50.
- Margolin L, Cope DK, Bakst-Sisser R, Greenspan J. The steroid withdrawal syndreome: a review of the implications, etiology and treatments. J Pain Symptoms Manage. 2007;33:224–8.
- Saracco P, Bertorello N, Farinasso L, Einaudi S, Barisone E, Altare F, et al. Steroid withdrawal syndrome during steroid tapering in childhood ALL. A controlled study comparing prednisone versus dexamethasone in induction phase. J Pediatr Hematol Oncol. 2005;27(3):141–4.
- Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Cancer Chemother Pharmacol. 2003;51:465–73.
- Mahachoklertwattana P, Vilaiyuk S, Hongeng S, Okascharoen C. Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents. J Pediatr. 2004;144:736–40.
- Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. J Clin Pharmacol. 1999;39:327–48.
- Nasrallah MP, Arafa BM. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. J Clin Endocrinol Metab. 2003;88:5293–8.
- Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's cancer Group. Blood 2003;101:3809–17.
- Shibata S, Kami M, Kanda Y, Machida U, Iwata H, Kishi Y, et al. Acute adrenal failure associated with fluconazole after administration of high dose cyclophosphamide. Am J Hematol. 2001;66(4):303–5.
- Balgaumi AF, Al-Bakrah M, Al-Mahr M, et al. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer 2003;97:2898–903.
- Wang YJ, Chu HY, Shu SG, Chi CS. Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases. Zhonghua Yi Xue Za Zhi (Taipei),1993;51(6):457–61.
- Sonabend RY, McKay SV, Okcu MF, Yan J, Haymond MW, Margolin JF. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2008;51(3):387–92.